English
Back
Download
Log in to access Online Inquiry
Back to the Top

$Pfizer (PFE.US)$ and $BioNTech (BNTX.US)$ announce Phase 3 ...

$Pfizer (PFE.US)$ and $BioNTech (BNTX.US)$ announce Phase 3 trial data showing efficacy of COVID-19 vaccine 30 microgram booster Shot:
• Preliminary results from any randomised, controlled COVID-19 vaccine booster trial indicate that the relative efficacy of the vaccine against the disease was 95.6% during the period when Delta was the circulating strain
• COVID-19 booster was found to have a good safety profile in trials of more than 10,000 participants aged 16 and older
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
18
1
+0
Translate
Report
33K Views
Comment
Sign in to post a comment
    404
    Followers
    12
    Following
    665
    Visitors
    Follow
    Discussing
    Trump 2.0 Era: What's the next opportunity in the markets?
    ▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks Show More